default author photo

Olaf Valverde Mordt

Drugs for Neglected Diseases Initiative (DNDi)

SCHOLARLY PAPERS

2

DOWNLOADS

161

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Fexinidazole as a New Oral Treatment for Human African Trypanosomiasis Due to Trypanosoma Brucei Rhodesiense: A Prospective, Open-Label, Single-Arm, Phase 2-3, Benchmark Study

Number of pages: 26 Posted: 08 Oct 2024
Makerere University, Rumphi District Hospital, Lwala Hospital, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Ministry of Health (Malawi), Republic of Uganda Ministry of Health, Institut de Recherche pour le Développement, University of Lisbon, University of Basel - Swiss Tropical and Public Health Institute, Drugs for Neglected Diseases Initiative (DNDi), Epicentre (Paris), Bruno Scherrer Conseil and Drugs for Neglected Diseases Initiative (DNDi)
Downloads 90 (742,061)

Abstract:

Loading...

fexinidazole, trypanosoma brucei rhodesiense, human African trypanosomiasis, clinical trial, Malawi, Uganda, efficacy, safety

2.

An Open-Label Study of the Effectiveness and Safety of Fexinidazole for Gambiense Human African Trypanosomiasis, Including an Exploration of Adherence in Outpatients

Number of pages: 28 Posted: 18 Apr 2024
Democratic Republic of Congo - Ministry of Health, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Human African Trypanosomiasis National Control Programm, Human African Trypanosomiasis National Control Programm, Ministry of Health and Public Hygiene (Guinea), Bagata Hospital, Bagata Hospital, Ministry of Health and Public Hygiene (Guinea), Dubreka Hospital, affiliation not provided to SSRN, Masi Manimba Hospital, Bandundu Hospital, Bandundu Hospital, Mushie Hospital, Mushie Hospital, Mushie Hospital, Roi Baudouin Hospital, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Bruno Scherrer Conseil and Drugs for Neglected Diseases Initiative (DNDi)
Downloads 71 (867,774)

Abstract:

Loading...

fexinidazole, phase IIIb, Democratic Republic of Congo, Guinea, trypanosomiasis, g-HAT, outpatient, Pregnant and breastfeeding women, children